Durham's BioCryst to test potential Ebola drug in early 2015

In an attempt to bring out a treatment for Ebola, Durham drug developer BioCryst Pharmaceuticals plans to test a new drug in humans early next year...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.